Skip to main content
Fig. 5 | EJNMMI Research

Fig. 5

From: In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [18F]FDG and [64Cu]Cu-LLP2A PET

Fig. 5

Representative CD49d/α4 (upper panel) and CD29/β1 (lower panel) surface expression levels in a MM.1S, b U266 cell lines analyzed by flow cytometry. c Comparison of CD49d mean fluorescence intensity (MFI) values among MM.1S and U266 cell lines. The non-specific surface binding was evaluated by isotype (IgG) controls. d Comparison of CD29 MFI values among MM.1S and U266 cell lines. Representative CD49d/α4 and CD29/β1 surface expression levels in BM cells of e MM.1S-CG cells injected mice, f U266-CG cells injected mice analyzed by flow cytometry

Back to article page